Risk of new retinal vascular occlusion after mRNA COVID-19 vaccination within aggregated electronic health record data I Dorney, J Shaia, DC Kaelber, KE Talcott, RP Singh JAMA ophthalmology 141 (5), 441-447, 2023 | 21 | 2023 |
A pilot study of the impact of virtually embodying a patient with a terminal illness CA Elzie, J Shaia Medical Science Educator 31, 665-675, 2021 | 17 | 2021 |
Increased medical student understanding of dementia through virtual embodiment JT Bard, HK Chung, JK Shaia, LL Wellman, CA Elzie Gerontology & Geriatrics Education 44 (2), 211-222, 2023 | 8 | 2023 |
Acute presentation of idiopathic intracranial hypertension with severe vision deficits JK Shaia, C Elzie SAGE Open Medical Case Reports 8, 2050313X20945573, 2020 | 8 | 2020 |
Early treatment patterns and outcomes in patients with diabetic macular edema treated with faricimab: the FARETINA-DME study D Borkar, D Tabano, V Garmo, T Leng, J Shaia, BL Kuo American Society of Retinal Specialists Annual Meeting. Seattle, 2023 | 6 | 2023 |
Virtually Walking in a Patient’s Shoes—the Path to Empathy? CA Elzie, J Shaia Medical Science Educator 30 (4), 1737-1739, 2020 | 6 | 2020 |
Changes in prevalence of idiopathic intracranial hypertension in the United States between 2015 and 2022, stratified by sex, race, and ethnicity JK Shaia, N Sharma, M Kumar, J Chu, C Maatouk, K Talcott, R Singh, ... Neurology 102 (3), e208036, 2024 | 4 | 2024 |
FARETINA-AMD-early treatment patterns and outcomes in patients with neovascular age-related macular degeneration initiating faricimab: an IRIS RegistryTM analysis DS Borkar, D Tabano, V Garmo, JK Shaia, B Kuo, R Myers, A LaPrise, ... Investigative Ophthalmology & Visual Science 64 (8), 2218-2218, 2023 | 3 | 2023 |
A Novel Three-Dimensional Drawing Activity to Learn the Dural Venous Sinuses. J Shaia, C Elzie HAPS Educator 23 (3), 499-501, 2019 | 3 | 2019 |
Characterisation and visual outcomes of fulminant idiopathic intracranial hypertension: a narrative review JK Shaia, J Markle, N Das, RP Singh, KE Talcott, DA Cohen Neuro-Ophthalmology, 1-13, 2024 | 2 | 2024 |
Characterization of the prevalence of visual impairment, ocular comorbidities, and mental health conditions in the United States N Sharma, J Chu, JK Shaia, R Singh, K Talcott Investigative Ophthalmology & Visual Science 64 (8), 1908-1908, 2023 | 2 | 2023 |
Longitudinal Trends and Disparities in Diabetic Retinopathy Within an Aggregate Health Care Network J Markle, JK Shaia, H Araich, N Sharma, KE Talcott, RP Singh JAMA ophthalmology, 2024 | 1 | 2024 |
FARETINA-DME-early treatment patterns and outcomes in patients with diabetic macular edema treated with faricimab: an IRIS RegistryTM analysis D Tabano, DS Borkar, V Garmo, JK Shaia, B Kuo, R Myers, A LaPrise, ... Investigative Ophthalmology & Visual Science 64 (8), 2699-2699, 2023 | 1 | 2023 |
Investigating the Relationship Between Lipid-lowering Agents and Diabetic Retinopathy Progression H Jeong, JK Shaia, K Talcott, R Singh Investigative Ophthalmology & Visual Science 65 (7), OD71-OD71, 2024 | | 2024 |
Frequency of Medication-Induced Intracranial Hypertension and Increased Odds of Fulminant Presentation of Disease J Rock, JK Shaia, K Talcott, R Singh, D Cohen Investigative Ophthalmology & Visual Science 65 (7), OD27-OD27, 2024 | | 2024 |
Fulminant Idiopathic Intracranial Hypertension and Potential Risk Factors I Trinh, JK Shaia, T Alam, J Rock, J Chu, K Talcott, R Singh, D Cohen Investigative Ophthalmology & Visual Science 65 (7), OD30-OD30, 2024 | | 2024 |
Associations of Androgen Exposure, PCOS, and Transmasculine Individuals with Central Serous Chorioretinopathy: A Cross-Sectional Study JD Shirian, N Das, JK Shaia, K Talcott, R Singh, DA Mammo Investigative Ophthalmology & Visual Science 65 (7), OD79-OD79, 2024 | | 2024 |
Investigating Risk of Stroke with Anti-VEGF in the Management of Neovascular AMD DD Chong, S Yue, I Murray, T Cuchta, J Raynor, JK Shaia, J Markle, ... Investigative Ophthalmology & Visual Science 65 (7), 232-232, 2024 | | 2024 |
Propensity matched analysis of the association between age-related macular degeneration and systemic autoimmune diseases P Shukla, MW Russell, J Muste, JK Shaia, M Kumar, A Nowacki, R Hajj-Ali, ... Investigative Ophthalmology & Visual Science 65 (7), 4371-4371, 2024 | | 2024 |
Risk of Audiologic Side Effects with Teprotumumab Treatment for Thyroid Eye Disease: A Multicenter Propensity-Matched Analysis J Markle, A Johanis, JK Shaia, D Benito, K Talcott, R Singh Investigative Ophthalmology & Visual Science 65 (7), 2427-2427, 2024 | | 2024 |